Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies
Clinical trial NCT00215605 · COMPLETED
Trial details
- NCT number
- NCT00215605
- Sponsor
- Exelixis
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2011-04-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.